Neuroimmunology

Browse Articles, recent Forum and News posts, Patient Handouts, External Resources, and Featured Images and Videos concerned with neuroimmunologic disorders.

In the Spotlight

Anti-NMDA receptor encephalitis
Autoantibodies: disease markers
Multiple sclerosis: clinical aspects
Paraneoplastic syndromes
Quality-of-life scales for neurologic diseases

Demyelinating Disorders

Acute disseminated encephalomyelitis
Acute necrotizing hemorrhagic leukoencephalitis
Balo concentric sclerosis
Clinically isolated syndrome
Fatigue in multiple sclerosis
Management of multiple sclerosis in COVID-19 pandemic
Multiple sclerosis and fertility
Multiple sclerosis: neurobehavioral aspects
Multiple sclerosis: neuroimmunology
Neurologic disorders associated with MOG antibodies
Neuromyelitis optica spectrum disorders
Optic neuritis
Optical coherence tomography in multiple sclerosis and neurologic disorders
Pediatric multiple sclerosis
Progressive multifocal leukoencephalopathy
Sleep and multiple sclerosis
Transverse myelitis
Tumefactive demyelinating lesions

Autoimmune Encephalitis & Related CNS Disorders

Anti-IgLON5 disease
Anti-LGI1 encephalitis
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
Hashimoto encephalopathy
Movement disorders associated with autoimmune encephalitis
Nonparaneoplastic autoimmune cerebellar diseases
Opsoclonus-myoclonus
Progressive encephalomyelitis with rigidity and myoclonus and glycine receptor antibodies
Stiff-person syndrome

Paraneoplastic Disorders

Lambert-Eaton myasthenic syndrome
Myositis and cancer
Paraneoplastic cerebellar degeneration
Paraneoplastic limbic encephalitis
Paraneoplastic opsoclonus myoclonus syndrome in adults
Paraneoplastic retinopathy
Paraneoplastic sensory neuronopathy

Inflammatory & Immune-Mediated Neuropathies

Acquired sensory neuronopathies
Acute inflammatory demyelinating polyradiculoneuropathy
Acute pandysautonomia
Autoimmune sensorineural hearing loss
Bell palsy
Chronic inflammatory demyelinating polyradiculoneuropathy
Guillain-Barre syndrome in children
Melkersson-Rosenthal syndrome
Miller Fisher syndrome and Bickerstaff brainstem encephalitis: anti-GQ1b antibody syndrome
Motor and multifocal motor neuropathies
Myasthenia gravis
Neuralgic amyotrophy
Neuropathies associated with cryoglobulinemia
POEMS syndrome
Polyneuropathy associated with anti-MAG IgM antibodies
Primary systemic amyloidosis: neurologic complications
Sarcoid neuropathy
Sensory neuropathies associated with anti-GD1b ganglioside antibodies

Localized & Systemic Vasculitis

Eosinophilic granulomatosis with polyangiitis
Primary CNS angiitis
Systemic small-vessel vasculitis
Takayasu arteritis
Temporal arteritis
Vasculitic neuropathies

Inflammatory & Immune-Mediated Myopathies

Dermatomyositis
Inclusion-body myositis
Polymyositis, necrotizing autoimmune myositis, myofasciitis, and overlap-myositis
Viral and retroviral myositis

Related Topics

Behcet disease
CLIPPERS
Endocrine neuroimmunology
Neurosarcoidosis
PANDAS
Rheumatoid arthritis: neurologic manifestations
Sjogren syndrome: neurologic complications
Susac syndrome
Systemic lupus erythematosus
Systemic sclerosis
Vogt-Koyanagi-Harada syndrome

Treatment Information

Alemtuzumab
Azathioprine
Clinical trials in multiple sclerosis
Dalfampridine
Dimethyl fumarate
Fingolimod
Glatiramer acetate
Infliximab
Interferon beta 1a
Interferon beta 1b
Intravenous immune globulin
Mitoxantrone
Multiple sclerosis: management
Multiple sclerosis: treatment of its symptoms
Mycophenolate
Natalizumab
Natalizumab and PML in MS
Ocrelizumab
Pyridostigmine
Vitamin D in neurologic disorders

Forum

Interact with your peers.

News

See what's being published in neurology and the neurosciences.

Childhood obesity could increase the risk of multiple sclerosis
Aug 25, 2020
Childhood and adolescent obesity is projected to contribute up to 14% of overall risk of multiple sclerosis in 2035.
Multiple sclerosis drug may be used to inhibit HIV infection and reduce latent reservoir
Aug 13, 2020
Fingolimod, used to treat multiple sclerosis flare-ups, may inhibit HIV replication and consequently reduce the latent reservoir.
Drug prevents multiple sclerosis relapses in phase 3 trial
Aug 06, 2020
Trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis.
View All

Patient Handouts

Print or email information for your patients when needed.

Acute disseminated encephalomyelitis
Miastenia gravis (Spanish)
Multiple sclerosis
Multiple sclerosis (condensed)
Myasthenia gravis

Guidelines

Other External Resources

Explore other relevant websites.

Featured Images and Videos

Learn from examples.

MRI of Cervical spinal cord in multiple sclerosis
MRI of Cervical spinal cord in multiple sclerosis
Neurosarcoidosis: base of third ventricle and optic tract MRI
MRI of Periventricular location of plaques in multiple sclerosis